Bridgeway Capital Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-51,500	Closed	-$111K	–	1311
2024 Q3	$111K	Hold	51,500	–	–	﹤0.01%	1152
2024 Q2	$266K	Hold	51,500	–	–	0.01%	992
2024 Q1	$276K	Buy	51,500 +12,000	+30%	+$83K	0.01%	1054
2023 Q4	$308K	Hold	39,500	–	–	0.01%	1059
2023 Q3	$156K	Hold	39,500	–	–	﹤0.01%	1141
2023 Q2	$124K	Sell	39,500 -10,000	-20%	-$32.1K	﹤0.01%	1223
2023 Q1	$132K	Buy	+49,500	New	+$192K	﹤0.01%	1181
2022 Q3	–	Sell	-9,500	Closed	-$91K	–	1460
2022 Q2	$91K	Sell	9,500 -7,500	-44%	-$70.2K	﹤0.01%	1238
2022 Q1	$202K	Hold	17,000	–	–	﹤0.01%	1170
2021 Q4	$554K	Buy	+17,000	New	+$688K	0.01%	953
2020 Q1	–	Sell	-3,330	Closed	-$230K	–	1368
2019 Q4	$230K	Hold	3,330	–	–	﹤0.01%	1177
2019 Q3	$346K	Hold	3,330	–	–	﹤0.01%	1063
2019 Q2	$308K	Sell	3,330 -4,000	-55%	-$279K	﹤0.01%	1090
2019 Q1	$670K	Buy	7,330 +740	+11%	+$51.5K	0.01%	911
2018 Q4	$367K	Sell	6,590 -2,000	-23%	-$152K	﹤0.01%	1086
2018 Q3	$1.02M	Hold	8,590	–	–	0.01%	870
2018 Q2	$877K	Sell	8,590 -1,380	-14%	-$171K	0.01%	924
2018 Q1	$1.29M	Buy	+9,970	New	+$1.09M	0.01%	747